S S Harris1, B Dawson-Hughes. 1. Jean Mayer United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA.
Abstract
OBJECTIVE: This analysis was conducted to compare wintertime 25-hydroxyvitamin D (25OHD) levels of young women who did and did not use oral contraceptives (OC). METHODS: The subjects were 66 Caucasian women aged 20 through 40 recruited from the Boston area. Plasma 25OHD was measured in February or March and again 1 year later. Other measurements included height, weight and vitamin D intake from diet and supplements. RESULTS: The initial mean 25OHD level of the 26 OC users was 41% higher than those of nonusers before adjustment for age and vitamin D intake (83 +/- 40 (sd) nmol/L compared with 59 +/- 22), and 39% higher after adjustment (p = 0.003). Five women who discontinued OC use during the year following their initial measurement all had decreases in their 25OHD levels (mean change was -25.5 +/- 17.7 (SD) nmol/L), whereas levels in women whose OC use or non-use was constant did not change. CONCLUSION: OC use increases circulating levels of 25OHD, and should be considered when interpreting values obtained for clinical evaluation or nutrition research.
OBJECTIVE: This analysis was conducted to compare wintertime 25-hydroxyvitamin D (25OHD) levels of young women who did and did not use oral contraceptives (OC). METHODS: The subjects were 66 Caucasian women aged 20 through 40 recruited from the Boston area. Plasma 25OHD was measured in February or March and again 1 year later. Other measurements included height, weight and vitamin D intake from diet and supplements. RESULTS: The initial mean 25OHD level of the 26 OC users was 41% higher than those of nonusers before adjustment for age and vitamin D intake (83 +/- 40 (sd) nmol/L compared with 59 +/- 22), and 39% higher after adjustment (p = 0.003). Five women who discontinued OC use during the year following their initial measurement all had decreases in their 25OHD levels (mean change was -25.5 +/- 17.7 (SD) nmol/L), whereas levels in women whose OC use or non-use was constant did not change. CONCLUSION: OC use increases circulating levels of 25OHD, and should be considered when interpreting values obtained for clinical evaluation or nutrition research.
Entities:
Keywords:
Americas; Biology; Comparative Studies; Contraception; Contraceptive Methods; Developed Countries; Family Planning; Massachusetts; Micronutrients; North America; Northern America; Oral Contraceptives; Physiology; Research Methodology; Research Report; Studies; United States; Vitamins
Authors: Bibiana García-Bailo; Andrea R Josse; Joseph Jamnik; Alaa Badawi; Ahmed El-Sohemy Journal: J Womens Health (Larchmt) Date: 2013-05 Impact factor: 2.681
Authors: B Dawson-Hughes; A Mithal; J-P Bonjour; S Boonen; P Burckhardt; G E-H Fuleihan; R G Josse; P Lips; J Morales-Torres; N Yoshimura Journal: Osteoporos Int Date: 2010-04-27 Impact factor: 4.507
Authors: Christina F Pelajo; Jorge M Lopez-Benitez; David M Kent; Lori Lyn Price; Laurie C Miller; Bess Dawson-Hughes Journal: Rheumatol Int Date: 2011-12-25 Impact factor: 2.631
Authors: Laura M Hall; Michael G Kimlin; Pavel A Aronov; Bruce D Hammock; James R Slusser; Leslie R Woodhouse; Charles B Stephensen Journal: J Nutr Date: 2010-01-06 Impact factor: 4.798
Authors: Pavan Bhargava; Sonya U Steele; Emmanuelle Waubant; Nisha R Revirajan; Jacqueline Marcus; Marieme Dembele; Sandra D Cassard; Bruce W Hollis; Ciprian Crainiceanu; Ellen M Mowry Journal: Mult Scler Date: 2015-08-18 Impact factor: 6.312
Authors: Shelley S Tworoger; Margaret A Gates; Margaret A Gate; I-Min Lee; Julie E Buring; Linda Titus-Ernstoff; Daniel Cramer; Susan E Hankinson Journal: Cancer Res Date: 2009-02-17 Impact factor: 12.701
Authors: Alan A Arslan; Tess V Clendenen; Karen L Koenig; Johan Hultdin; Kerstin Enquist; Asa Agren; Annekatrin Lukanova; Hubert Sjodin; Anne Zeleniuch-Jacquotte; Roy E Shore; Göran Hallmans; Paolo Toniolo; Eva Lundin Journal: J Oncol Date: 2009-08-27 Impact factor: 4.375